Variability of Serum Concentration of Calcium, Phosphate and Parathyroid Hormone Depending on Time of Blood Draw for Patients on Nocturnal Home Hemodialysis
- 1 Department of Medicine, Division of Nephrology, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Canada
- 2 Department of Medicine, Division of Nephrology, Ottawa Hospital, Ottawa, Canada
- 3 Department of Medicine, Division of Nephrology, Ottawa Hospital, Ottawa, Canada;Kidney Research Centre of the Ottawa Hospital Research Institute, Ottawa, Canada
- 4 Department of Medicine, Division of Nephrology, Ottawa Hospital, Ottawa, Canada;Kidney Research Centre of the Ottawa Hospital Research Institute, Ottawa, Canada
Abstract
Background: Guidelines for patients treated with conventional hemodialysis patients have been written for target serum levels for calcium (Ca), phosphate (PO 4 ) and intact parathyroid hormone (iPTH). No guidelines exist for nocturnal home hemodialysis (NHHD) patients for target values or timing of the blood sample draw. We undertook a prospective cohort study to examine the variability in pre, post and clinic (post-post) serum values for Ca, PO 4 , and iPTH in NHHD patients to determine if timing of blood draw could affect clinical decisions. Methods: Twenty prevalent NHHD patients collected blood pre and post their usual NHHD session with an additional blood sample drawn in clinic (post-post). Median and interquartile range of pre, post and clinic (post-post) values of iPTH, PO 4 and Ca were calculated and compared with Freidman/Wilcoxon test. Serum concentrations were also categorized according to Canadian Society of Nephrology (CSN) guidelines target values for pre and clinic (post-post) samples. The proportion of patients that would be categorized differently by clinic (post-post) samples was determined. Results: There was a significant difference between pre-serum values compared to post and clinic (post-post) values. Overall, iPTH, PO 4 and Ca values would be misclassified in 25%, 70% and 50% respectively if blood was drawn at the clinic visit (post-post) compared to pre-HD as per CSN guidelines. Conclusions: Although no specific guideline has been written for NHHD patients, to ensure consistency of management compared to in-centre HD patients, lab values should be drawn pre-HD until clinical evidence suggests that the recommendations should be different for NHHD.
- A. Laupacis, P. Keown, N. Pus, et al., “A Study of the Quality of Life and Cost-Utility of Renal Transplant,” Kidney International, Vol. 50, No. 1, 1996, pp. 235-242. doi:10.1038/ki.1996.307
- B. F. Culleton, M. Walsh, S. W. Klarenbach, et al., “Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial,” Journal of the American Medical Association, Vol. 298, No. 11, 2007, pp. 1291-1299. doi:10.1001/jama.298.11.1291
- P. A. McFarlane, A. M. Bayoumi, A. Pierratos and D. A. Redelmeier, “The Quality of Life and Cost Utility of Home Nocturnal and Conventional in-Center Hemodialysis,” Kidney International, Vol. 64, No. 3, 2003, pp. 1004-1011. doi:10.1046/j.1523-1755.2003.00157.x
- M. V. Rocco, R. S. Lockridge, Jr, G. J. Beck, et al., “The Effects of Frequent Nocturnal Home Hemodialysis: The Frequent Hemodialysis Network Nocturnal Trial,” Kidney International, Vol. 80, No. 10, 2011, pp. 1080-1091. doi:10.1038/ki.2011.213
- M. John and K. Michael, “Starting a Home Hemodialysis Program,” Seminars in Dialysis, Vol. 20, No. 1, 2007, pp. 35-39. doi:10.1111/j.1525-139X.2007.00239.x
- R. Mactier, N. Hoenich, C. Breen, “Renal Assocition Clinical Practice Guidelines 5th Edition 2009-2012,” Nephron Clinical Practice, Vol. 118, Suppl. 1, 2011, pp. 241-286.
- S. Moe, T. Drueke, J. Cunningham, et al., “Definition, Evaluation, and Classification of Renal Osteodystrophy: A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO),” Kidney International, Vol. 69, No. 11, 2006, pp. 1945-1953. doi:10.1038/sj.ki.5000414
- W. G. Goodman, J. Goldin, B. D. Kuizon, et al., “Coronary Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis,” The New England Journal of Medicine, Vol. 342, No. 20, 2000, pp. 1478-1483. doi:10.1056/NEJM200005183422003
- W. Y. Qunibi, C. A. Nolan and J. C. Ayus, “Cardiovascular Calcification in Patients with End-Stage Renal Disease: A Century Old Phenomenon,” Kidney International, Vol. 62, Suppl. 82, 2002, pp. S73-S80. doi:10.1046/j.1523-1755.62.s82.15.x
- G. A. Block, P. S. Klassen, J. M. Lazarus, N. Ofsthun, E. G. Lowrie and G. M. Chertow, “Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis,” Journal of the American Society of Nephrology, Vol. 15, No. 8, 2004, pp. 2208-2218. doi:10.1097/01.ASN.0000133041.27682.A2,
- M. L. Melamed, J. A. Eustace, L. Plantinga, et al., “Changes in Serum Calcium, Phosphate, and PTH and the Risk of Death in Incident Dialysis Patients: Along Longitudinal Study,” Kidney International, Vol. 70, 2006, pp. 351-357. doi:10.1038/sj.ki.5001542